3,6-DMAD dihydrochloride (0-6 μM; 24 h; RPMI 8226 and MM1.R human MM cells) has cytotoxicity against MM cell lines.
3,6-DMAD dihydrochloride (0-30 μM; 14 h; HT1080 cells treated with Tg (0.3 μM)) inhibits XBP1 splicing (XBP1s) in a dose dependent manner.
3,6-DMAD dihydrochloride (0.1-500 μM; 14 h; HT1080 cells treated with Tg (0.3 μM)) inhibits IRE1α endonuclease activity.
3,6-DMAD dihydrochloride (1-60 μM; 2 h; HEK293 cells) inhibits IRE1α oligomerization and IRE1α-GFP foci formation.
Cell Viability Assay
| Cell Line: |
RPMI 8226 and MM1.R human MM cells |
| Concentration: |
0, 0.5, 1, 2, 3, 4, 5 and 6 μM |
| Incubation Time: |
24 hours |
| Result: |
| Inhibited cell survival rate in a dose dependent manner. |
|
Cell Viability Assay
| Cell Line: |
0, 5, 10 and 30 μM |
| Concentration: |
0, 0.5, 1, 2, 3, 4, 5 and 6 μM24 hours |
| Incubation Time: |
14 hours |
| Result: |
| Showed XBP1s inhibition at as low as 0.5 μM. |
|